Teva-Nabilone 0.25 mg (Nabilone CAPSULE) 0.25 MG

TEVA-Nabilone 0.25 mg capsules are a synthetic cannabinoid used for managing symptoms like nausea and vomiting. This oral medication is manufactured by Teva Canada Limited and comes in a pack of 50 capsules.

Strength

0.25 MG

Pack Size

Manufacturer / TM Owner

TEVA CANADA LIMITED

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

TEVA-Nabilone 0.25 mg capsules are primarily used to alleviate nausea and vomiting, particularly in patients undergoing chemotherapy. This medication is a synthetic cannabinoid, designed to interact with the body's cannabinoid receptors. People often ask, 'What is Nabilone used for?' and the answer is that it is commonly prescribed for symptom management in cancer treatment.

Side Effects

Common effects of TEVA-Nabilone 0.25 mg capsules may include drowsiness, dizziness, and dry mouth. Some users also report feelings of euphoria or anxiety. These effects can vary from person to person and may depend on individual tolerance and dosage.

Precautions & Warnings

TEVA-Nabilone 0.25 mg capsules should be handled with care. It is important to follow the prescribed dosage and avoid activities that require alertness, such as driving, until you know how the medication affects you. Store the capsules in a cool, dry place away from direct sunlight.

Avoid Interactions

TEVA-Nabilone 0.25 mg capsules can interact with other medications, including alcohol and central nervous system depressants. It is advisable to consult a healthcare provider before combining Nabilone with other substances, as interactions can enhance or diminish the effects of the medication.

Frequently Asked Questions

Nabilone is primarily used to manage nausea and vomiting, especially in patients undergoing chemotherapy.

TEVA-Nabilone 0.25 mg capsules are taken orally, typically with water. Follow the dosage instructions provided by your healthcare provider.

Common side effects include drowsiness, dizziness, dry mouth, and feelings of euphoria or anxiety.

It is generally advised to avoid alcohol while taking Nabilone, as it can enhance the medication's effects and cause unwanted side effects.

Store the capsules in a cool, dry place away from direct sunlight and out of reach of children.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.